Order no. |
Antibody specificity / |
Ig |
Substrate |
Species |
Format |
EI 2721-9601-1 A |
Parainfluenza virus |
IgA |
|
semi-quantitative |
96 x 01 |
EI 2721-9601-1 G |
Parainfluenza virus types 1 - 4 (Pool) |
IgG |
2/20/200 RU/ml |
96 x 01 | |
EI 2721-9601-1 M | Parainfluenza virus types 1 - 4 (Pool) incl. IgG/RF absorbent | IgM |
semi-quantitative |
96 x 01 | |
FI 2721-1005-1 A FI 2721-1005-1 G FI 2721-1005-1 M |
Mosaic Parainfluenza virus types 1 - 4 | IgA IgG IgM |
4 BIOCHIPs per field: infected cells |
EU 18/9 |
10 x 05 (test system) 10 x 05 (test system) 10 x 05 (test system) |
FI 2821-1001-1 G FI 2821-1002-1 G FI 2821-2002-1 G FI 2821-1001-1 M FI 2821-1002-1 M FI 2821-2002-1 M |
Respiratory Tract Profile 1 (consisting of 21 different substrates) |
IgG IgM |
field A: verification BIOCHIP, RSV, Adenovirus type 3, Influenza virus type A (H1N1 and H3N2) field B: Influenza virus type B, Parainfluenza virus type 1, 2, 3 field C: Parainfluenza virus type 4, Bordetella pertussis and parapertussis, Mycoplasma pneumoniae field D: Coxsackie virus type B1 and A7, Echo virus type 7, Chlamydia pneumoniae field E: Haemophilus influenzae*, Klebsiella pneumoniae*,Legionella pneumophila serotype 1 and 12 |
10 x 01 (test system) 10 x 02 (test system) 20 x 02 (test system) 10 x 01 (test system) 10 x 02 (test system) 20 x 02 (test system) |
|
FI 2823-1001-1 G * FI 2823-1002-1 G * FI 2823-1001-1 M * FI 2823-1002-1 M * |
Lymphadenitis Profile 1 (consisting of 21 different substrates) |
IgG IgM |
field A: verification BIOCHIP, HIV-1* and 2*, HHV-6, Rubella virus* field B: measles virus, Mumps virus, Adenovirus type 3, Parainfluenza virus type 1 field C: EBV-CA, EBV-EA, Toxoplasma gondii, Treponema pallidum field D: HSV-1 and -2, CMV, Coxsackie virus type B5 field E: Coxsackie virus type A9, Bartonella henselae, Chlamydia trachomatis and pneumoniae |
10 x 01 (test system) 10 x 02 (test system) 10 x 01 (test system) 10 x 02 (test system) |
|
FI 2825-1001-1 G FI 2825-1002-1 G FI 2825-1001-1 M FI 2825-1002-1 M |
Myocarditis Profile 1 (consisting of 17 different substrates) |
IgG IgM |
field A: verification BIOCHIP, Mumps virus, Adenovirus type 3, Influenza virus type A (H1N1 and H3N2) field B: Influenza virus Typ B, Parainfluenza virus type 1 and 2, Mycoplasma pneumoniae field C: CMV, Coxsackie virus type B1 and A16, Echo virus type 7 field D: Borrelia afzelii, burgdorferi (CH),garinii, Chlamydia pneumoniae |
|
10 x 01 (test system) 10 x 02 (test system) 10 x 01 (test system) 10 x 02 (test system) |
CI 2720-0101 A | antibodies against Parainfluenza virus types 1 - 4 IgA positive control |
IgA |
|
0.1 ml | |
CI 2720-0101 Z | Parainfluenza virus negative control |
IgA, IgG, IgM |
0.1 ml | ||
CI 2720-0101 G | antibodies against Parainfluenza virus types 1 - 4 IgG positive control |
IgG |
0.1 ml | ||
CI 2720-0101 M | antibodies against Parainfluenza virus types 1 - 4 IgM positive control |
IgM |
0.1 ml |
*) Currently not available as IVD in the European Union.
Order no. |
Antibody specificity / |
Ig |
Substrate |
Species |
Format |
EI 2721-9601-1 A |
Parainfluenza virus |
IgA |
|
semi-quantitative |
96 x 01 |
EI 2721-9601-1 G |
Parainfluenza virus types 1 - 4 (Pool) |
IgG |
2/20/200 RU/ml |
96 x 01 | |
EI 2721-9601-1 M | Parainfluenza virus types 1 - 4 (Pool) incl. IgG/RF absorbent | IgM |
semi-quantitative |
96 x 01 | |
FI 2721-1005-1 A FI 2721-1005-1 G FI 2721-1005-1 M |
Mosaic Parainfluenza virus types 1 - 4 | IgA IgG IgM |
4 BIOCHIPs per field: infected cells |
EU 18/9 |
10 x 05 (test system) 10 x 05 (test system) 10 x 05 (test system) |
FI 2821-1001-1 G FI 2821-1002-1 G FI 2821-2002-1 G FI 2821-1001-1 M FI 2821-1002-1 M FI 2821-2002-1 M |
Respiratory Tract Profile 1 (consisting of 21 different substrates) |
IgG IgM |
field A: verification BIOCHIP, RSV, Adenovirus type 3, Influenza virus type A (H1N1 and H3N2) field B: Influenza virus type B, Parainfluenza virus type 1, 2, 3 field C: Parainfluenza virus type 4, Bordetella pertussis and parapertussis, Mycoplasma pneumoniae field D: Coxsackie virus type B1 and A7, Echo virus type 7, Chlamydia pneumoniae field E: Haemophilus influenzae*, Klebsiella pneumoniae*,Legionella pneumophila serotype 1 and 12 |
10 x 01 (test system) 10 x 02 (test system) 20 x 02 (test system) 10 x 01 (test system) 10 x 02 (test system) 20 x 02 (test system) |
|
FI 2823-1001-1 G * FI 2823-1002-1 G * FI 2823-1001-1 M * FI 2823-1002-1 M * |
Lymphadenitis Profile 1 (consisting of 21 different substrates) |
IgG IgM |
field A: verification BIOCHIP, HIV-1* and 2*, HHV-6, Rubella virus* field B: measles virus, Mumps virus, Adenovirus type 3, Parainfluenza virus type 1 field C: EBV-CA, EBV-EA, Toxoplasma gondii, Treponema pallidum field D: HSV-1 and -2, CMV, Coxsackie virus type B5 field E: Coxsackie virus type A9, Bartonella henselae, Chlamydia trachomatis and pneumoniae |
10 x 01 (test system) 10 x 02 (test system) 10 x 01 (test system) 10 x 02 (test system) |
|
FI 2825-1001-1 G FI 2825-1002-1 G FI 2825-1001-1 M FI 2825-1002-1 M |
Myocarditis Profile 1 (consisting of 17 different substrates) |
IgG IgM |
field A: verification BIOCHIP, Mumps virus, Adenovirus type 3, Influenza virus type A (H1N1 and H3N2) field B: Influenza virus Typ B, Parainfluenza virus type 1 and 2, Mycoplasma pneumoniae field C: CMV, Coxsackie virus type B1 and A16, Echo virus type 7 field D: Borrelia afzelii, burgdorferi (CH),garinii, Chlamydia pneumoniae |
|
10 x 01 (test system) 10 x 02 (test system) 10 x 01 (test system) 10 x 02 (test system) |
CI 2720-0101 A | antibodies against Parainfluenza virus types 1 - 4 IgA positive control |
IgA |
|
0.1 ml | |
CI 2720-0101 Z | Parainfluenza virus negative control |
IgA, IgG, IgM |
0.1 ml | ||
CI 2720-0101 G | antibodies against Parainfluenza virus types 1 - 4 IgG positive control |
IgG |
0.1 ml | ||
CI 2720-0101 M | antibodies against Parainfluenza virus types 1 - 4 IgM positive control |
IgM |
0.1 ml |
*) Currently not available as IVD in the European Union.